BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roguljic H, Nincevic V, Bojanic K, Kuna L, Smolic R, Vcev A, Primorac D, Vceva A, Wu GY, Smolic M. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Front Pharmacol 2021;12:678546. [PMID: 34045969 DOI: 10.3389/fphar.2021.678546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lam L, Fontaine H, Lapidus N, Dorival C, Bellet J, Larrey D, Nahon P, Diallo A, Cagnot C, Lusivika-Nzinga C, Téoulé F, Hejblum G, Bourlière M, Pol S, Carrat F; ANRS/AFEF Hepather study group. Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers. Pharmacoepidemiol Drug Saf 2023;32:486-95. [PMID: 36444965 DOI: 10.1002/pds.5576] [Reference Citation Analysis]
2 Nakagawa M, Asahina Y, Kakinuma S, Okamoto R. Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. J Gastroenterol 2022. [PMID: 36585501 DOI: 10.1007/s00535-022-01940-1] [Reference Citation Analysis]
3 Bale BF, Doneen AL, Leimgruber PP, Vigerust DJ. The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1042729] [Reference Citation Analysis]
4 Ramadan MS, Boccia F, Moretto SM, De Gregorio F, Gagliardi M, Iossa D, Durante-Mangoni E, Zampino R. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. J Clin Med 2022;11. [PMID: 36233646 DOI: 10.3390/jcm11195781] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gîrleanu I, Trifan A, Huiban L, Muzîca C, Petrea OC, Sîngeap AM, Cojocariu C, Chiriac S, Cuciureanu T, Costache II, Stanciu C. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury. Life (Basel) 2022;12:1036. [PMID: 35888123 DOI: 10.3390/life12071036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Yang W, Wang Y, Zhang P, Wang T, Li C, Tong X, Zeng X, Yin Y, Tao K, Li R, Kolaczkowska E. Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/5766434] [Reference Citation Analysis]